The impact of extended pelvic lymph node dissection on the risk of hospital readmission within 180 days after robot assisted radical prostatectomy

被引：15

作者：

Sebben, Marco ^{[1
]}

Tafuri, Alessandro ^{[1
,2
,3
]}

Shakir, Aliasger ^{[2
,3
]}

Pirozzi, Marco ^{[1
]}

Processali, Tania ^{[1
]}

Rizzetto, Riccardo ^{[1
]}

Amigoni, Nelia ^{[1
]}

Tiso, Leone ^{[1
]}

De Michele, Mario ^{[1
]}

Panunzio, Andrea ^{[1
]}

Cerrato, Clara ^{[1
]}

Brunelli, Matteo ^{[4
]}

Migliorini, Filippo ^{[1
]}

Novella, Giovanni ^{[1
]}

De Marco, Vincenzo ^{[1
]}

Siracusano, Salvatore ^{[1
]}

Artibani, Walter ^{[1
]}

Porcaro, Antonio Benito ^{[1
]}

机构：

[1] Univ Verona, Azienda Osped Univ Integrata Verona, Dept Urol, Piazzale Stefani 1, I-37126 Verona, Italy

[2] Univ Southern Calif, Inst Urol, Los Angeles, CA 90007 USA

[3] Univ Southern Calif, Catherine & Joseph Aresty Dept Urol, Los Angeles, CA 90007 USA

[4] Univ Verona, Azienda Osped Univ Integrata Verona, Dept Pathol, Verona, Italy

来源：

WORLD JOURNAL OF UROLOGY | 2020年 / 38卷 / 11期

关键词：

Prostate cancer; Radical prostatectomy; Robotic surgery; Hospital readmission; Complications; SEMINAL-VESICLE INVASION; CLINICAL FACTORS; CANCER PATIENTS; PREDICTORS; COMPLICATIONS; GUIDELINES; CARCINOMA; PROPOSAL; DISEASE; COHORT;

D O I：

10.1007/s00345-020-03094-2

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Objective To evaluate the factors associated with the risk of hospital readmission after robot assisted radical prostatectomy (RARP) with or without extended pelvic lymph node dissection (ePLND) for prostate cancer (PCA) over a long term. Materials and methods The risk of readmission was evaluated by clinical, pathological, and perioperative factors. Skilled and experienced surgeons performed the procedures. Patients were followed for complications and hospital readmission for a period of six months. The logistic regression model and Cox's proportional hazards assessed the association of factors with the risk of readmission. Results From January 2013 to December 2018, 890 patients underwent RARP; ePLND was performed in 495 of these patients. Hospital readmission was detected in 25 cases (2.8%); moreover, it was more frequent when RARP was performed with ePLND (4.4% of cases) than without (0.8% of patients). On the final multivariate model, ePLND was the only independent factor that was positively associated with the risk of hospital readmission (hazard ratio, HR = 5935; 95%CI 1777-19,831; p = 0.004). Conclusions Over the long term after RARP for PCA, the risk of hospital readmission is associated with ePLND. In patients who underwent RARP and ePLND, 4.4% of them had a readmission, compared to RARP alone, in which only 0.8% of cases had a readmission. When ePLND is planned for staging pelvic lymph nodes, patients should be informed of the increased risk of hospital readmission.

引用

页码：2799 / 2809

页数：11

共 41 条

[1] Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review [J].